Phisoderm Anti-Blemish Gel Cleanser

Description

Phisoderm Anti-Blemish Gel Cleanser is a topical formulation designed for the management of acne-prone skin. This gel cleanser effectively targets blemishes while cleansing the skin. The product is characterized by its clear, gel-like consistency, which facilitates easy application and thorough cleansing. It is formulated to help reduce the appearance of acne and prevent future breakouts, making it suitable for individuals with oily or combination skin types.

Uses and Indications

This drug is indicated for the treatment and prevention of acne blemishes.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to instruct patients to wet their face prior to application. The product should be gently massaged onto the skin, ensuring even coverage. Following application, it is essential to rinse the product thoroughly with water and pat the skin dry. This regimen should be followed twice daily for optimal results.

Contraindications

Use is contraindicated in patients with a history of eye contact, as exposure may lead to irritation; in such cases, the eyes should be flushed thoroughly with water. Concurrent use with other topical acne medications is also contraindicated due to an increased risk of skin irritation and dryness. It is recommended to use only one topical acne medication at a time to minimize these risks.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes; in the event of contact, the affected area should be flushed thoroughly with water to mitigate potential irritation.

The concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. To minimize the risk of adverse effects, it is recommended that only one topical acne medication be used at a time.

Healthcare professionals should advise patients who are pregnant or breastfeeding to consult with a health professional prior to using this product to ensure safety for both the mother and child.

In cases of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay to address potential health risks.

Side Effects

Patients using this product should be aware that it is for external use only. It is important to avoid contact with the eyes; in the event of contact, the affected area should be flushed thoroughly with water.

Skin irritation and dryness are common adverse reactions associated with the use of this product, particularly if patients concurrently use another topical acne medication. To minimize the risk of irritation, it is advised that only one topical acne medication be used at a time.

Additionally, patients who are pregnant or breastfeeding should consult a health professional before using this product to ensure safety for both themselves and their child.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Phisoderm Anti-Blemish Gel Cleanser (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of PHISODERM ANTI-BLEMISH GEL CLEANSER in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of the patient's response to treatment.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. Therefore, it is essential for women of childbearing potential to seek medical advice prior to use to ensure appropriate management and consideration of any potential risks.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include airway management, monitoring of vital signs, and intravenous fluid administration as necessary. The use of specific antidotes or treatments should be guided by the clinical scenario and the substances involved.

Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for further guidance on the management of overdose cases. Documentation of the incident and any interventions performed is crucial for ongoing patient care and safety.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the importance of prompt action in such situations.

Providers should also emphasize the need to avoid contact with the eyes. Instruct patients that if contact occurs, they should flush the eyes thoroughly with water to minimize potential irritation.

Additionally, healthcare providers should inform patients about the risk of skin irritation and dryness associated with the use of this medication, particularly if they are using another topical acne treatment concurrently. It is recommended that patients use only one topical acne medication at a time to reduce the likelihood of irritation.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, away from excessive heat and direct sunlight to ensure optimal conditions. After opening, the product should be discarded to prevent any potential degradation or contamination.

Additional Clinical Information

The medication is administered topically and is recommended for use twice daily. Clinicians should advise patients who are pregnant or breastfeeding to consult a health professional prior to use. It is important to avoid contact with the eyes; in the event of contact, patients should flush the area thoroughly with water. Patients should also be informed that using this medication concurrently with other topical acne treatments may increase the likelihood of skin irritation and dryness. Therefore, if irritation occurs, it is advisable to limit the use to one topical acne medication at a time.

Drug Information (PDF)

This file contains official product information for Phisoderm Anti-Blemish Gel Cleanser, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)